Phase II study of capecitabine in substitution of 5-FU in the chemoradiotherapy regimen for patients with squamous cell carcinoma of the anal canal

Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPRIBEIRO, Suilane CoelhoMONIZ, Camila Motta VenchiaruttiRIECHELMANN, RachelBARIANI, Giovanni MendoncaBRAGHIROLI, Maria IgnezNAHAS, CaioCOUDRY, RenataALEX, Alexandra KhichfyCARNEIRO, Allyne Q.NEBULONI, Daniela R.GLASBERG, JoaoHOFF, Paulo2014-07-182014-07-182014JOURNAL OF CLINICAL ONCOLOGY, v.32, n.3, suppl.S, 20140732-183Xhttps://observatorio.fm.usp.br/handle/OPI/6316engopenAccessPhase II study of capecitabine in substitution of 5-FU in the chemoradiotherapy regimen for patients with squamous cell carcinoma of the anal canalconferenceObjectCopyright AMER SOC CLINICAL ONCOLOGYOncology1527-7755